Life-Science Startups
Life-Science Startups
Regenerative medicine / Stem cells / Signal peptides.
Toyo Bijin Capital · A Letter to Long‑Term Capital
The Group's strategic investment arm is not an independent fund, nor does it raise capital externally — its source of funds is the endogenous capital accumulated by the Group over a century.
The Other Wheel
"Letting the most patient research meet the most enduring capital."
This promise belongs to the Kyoto Life Sciences Institute as well as to Toyo Bijin Capital. The life sciences engine and the strategic investment engine are not two parallel departments, but two gears of the same century-long commitment.
Toyo Bijin Capital exists not so that the Group might "also do some investing," but so that the Group's R&D cycles are no longer hijacked by the quarterly rhythm of markets — capital patience is the physical precondition of research patience.
Three Convictions
Long‑Termism
Each investment cycle is at least 7-10 years, aligned with the R&D cycle of the Kyoto Institute. We do not chase quarterly returns; we walk alongside a journey of science.
Reciprocity
The technology of portfolio companies can be absorbed and transformed by the Group's product lines — this is the tooth where the dual engines of "capital" and "research" truly mesh.
Scientific Patience
We invest not only in companies but in scientists themselves. We believe that treating researchers with patience is the only reliable source of long‑term return.
Life-Science Startups
Regenerative medicine / Stem cells / Signal peptides.
Women's Health Frontier
Echoing Bijin Privé and the Group's Women's Wellness Initiative.
Sustainable Beauty Materials
Echoing the Group's environmental commitment, driving the industry toward green chemistry.
· Aligned with the Group's R&D strategy.
· Aligned with the Group's sustainability strategy.
· We do not invest in financial-arbitrage projects unrelated to the Group's core mission — however tempting the short-term return.
This boundary is the most fundamental difference between Toyo Bijin Capital and an ordinary financial-type fund.
"A senior scientist once backed by Toyo Bijin Capital,
after years of repair-focused research,
saw the fruits transformed into a core ingredient of the Group's next-generation intimate products."
Industry, Innovation & Infrastructure
Partnerships for the Goals